Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Azilsartan can restore circadian rhythm of the urinary sodium excretion

Trial Profile

Azilsartan can restore circadian rhythm of the urinary sodium excretion

Completed
Phase of Trial: Phase IV

Latest Information Update: 06 Nov 2017

At a glance

  • Drugs Azilsartan (Primary)
  • Indications Hypertension
  • Focus Pharmacodynamics
  • Most Recent Events

    • 03 Nov 2017 Status changed from recruiting to completed.
    • 16 Jan 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top